345 related articles for article (PubMed ID: 25198786)
1. Na+/K+ ATPase inhibitors in cancer.
Alevizopoulos K; Calogeropoulou T; Lang F; Stournaras C
Curr Drug Targets; 2014; 15(10):988-1000. PubMed ID: 25198786
[TBL] [Abstract][Full Text] [Related]
2. Modulators of Na/K-ATPase: a patent review.
Wang HY; O'Doherty GA
Expert Opin Ther Pat; 2012 Jun; 22(6):587-605. PubMed ID: 22595010
[TBL] [Abstract][Full Text] [Related]
3. Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.
Durlacher CT; Chow K; Chen XW; He ZX; Zhang X; Yang T; Zhou SF
Clin Exp Pharmacol Physiol; 2015 May; 42(5):427-43. PubMed ID: 25739707
[TBL] [Abstract][Full Text] [Related]
4. Steroidal cardiac Na+/K+ ATPase inhibitors exhibit strong anti-cancer potential in vitro and in prostate and lung cancer xenografts in vivo.
Dimas K; Papadopoulou N; Baskakis C; Prousis KC; Tsakos M; Alkahtani S; Honisch S; Lang F; Calogeropoulou T; Alevizopoulos K; Stournaras C
Anticancer Agents Med Chem; 2014 Jun; 14(5):762-70. PubMed ID: 24066843
[TBL] [Abstract][Full Text] [Related]
5. Na
Bejček J; Spiwok V; Kmoníčková E; Rimpelová S
Molecules; 2021 Mar; 26(7):. PubMed ID: 33800655
[TBL] [Abstract][Full Text] [Related]
6. Na+/K+-ATPase and cancer.
Mijatovic T; Dufrasne F; Kiss R
Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
[TBL] [Abstract][Full Text] [Related]
7. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.
Alevizopoulos K; Dimas K; Papadopoulou N; Schmidt EM; Tsapara A; Alkahtani S; Honisch S; Prousis KC; Alarifi S; Calogeropoulou T; Lang F; Stournaras C
Oncotarget; 2016 Apr; 7(17):24415-28. PubMed ID: 27027435
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.
Zeino M; Brenk R; Gruber L; Zehl M; Urban E; Kopp B; Efferth T
J Steroid Biochem Mol Biol; 2015 Jun; 150():97-111. PubMed ID: 25797029
[TBL] [Abstract][Full Text] [Related]
10. New insights into the regulation of Na+,K+-ATPase by ouabain.
Silva E; Soares-da-Silva P
Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
[TBL] [Abstract][Full Text] [Related]
11. Update on the effects of the sodium pump α1 subunit on human glioblastoma: from the laboratory to the clinic.
Lan YL; Yu ZL; Lou JC; Ma XC; Zhang B
Expert Opin Investig Drugs; 2018 Sep; 27(9):753-763. PubMed ID: 30130132
[TBL] [Abstract][Full Text] [Related]
12. Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy.
Felippe Gonçalves-de-Albuquerque C; Ribeiro Silva A; Ignácio da Silva C; Caire Castro-Faria-Neto H; Burth P
Molecules; 2017 Apr; 22(4):. PubMed ID: 28430151
[TBL] [Abstract][Full Text] [Related]
13. Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failure.
Liu CC; Fry NA; Hamilton EJ; Chia KK; Garcia A; Karimi Galougahi K; Figtree GA; Clarke RJ; Bundgaard H; Rasmussen HH
J Mol Cell Cardiol; 2013 Aug; 61():94-101. PubMed ID: 23727392
[TBL] [Abstract][Full Text] [Related]
14. Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Ferrari P; Giacalone G; Marazzi G; Moro B; Micheletti R; Sputore S; Torri M; Zappavigna MP; Cerri A
Bioorg Med Chem; 2010 Jun; 18(12):4275-99. PubMed ID: 20494582
[TBL] [Abstract][Full Text] [Related]
15. Cardiotonic steroids on the road to anti-cancer therapy.
Mijatovic T; Van Quaquebeke E; Delest B; Debeir O; Darro F; Kiss R
Biochim Biophys Acta; 2007 Sep; 1776(1):32-57. PubMed ID: 17706876
[TBL] [Abstract][Full Text] [Related]
16. [Cancer cell-specific functional relation between Na
Fujii T; Shimizu T; Takeshima H; Sakai H
Nihon Yakurigaku Zasshi; 2019; 154(3):103-107. PubMed ID: 31527358
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of panaxatriol derivatives as Na
Wu Q; Chen P; Tu G; Li M; Pan B; Guo Y; Zhai J; Fu H
Bioorg Med Chem Lett; 2018 Sep; 28(17):2885-2889. PubMed ID: 30049579
[TBL] [Abstract][Full Text] [Related]
18. Na+/K+-ATPase alpha subunits as new targets in anticancer therapy.
Mijatovic T; Ingrassia L; Facchini V; Kiss R
Expert Opin Ther Targets; 2008 Nov; 12(11):1403-17. PubMed ID: 18851696
[TBL] [Abstract][Full Text] [Related]
19. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
[TBL] [Abstract][Full Text] [Related]
20. [The ability of cells to adjust to the low oxigen content associated with Na,K-ATPase glutationilation].
Petrushanko IIu; Simonenko OV; Burnysheva KM; Klimanova EA; Dergousova EA; Mit'kevich VA; Lopina OD; Makarov AA
Mol Biol (Mosk); 2015; 49(1):175-83. PubMed ID: 25916122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
